The association between HSP90 acetylation and reduced CCA cell growth and migration was consistently observed in the present study, suggesting that aberrant HSP90 acetylation may contribute to the attenuation of CCA oncogenic properties. The gene discussed is HSP90AB1; the disease is cholangiocarcinoma.